Efficacy of Aprepitant (Emend®) in Children
NCT01661335
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Nausea
Vomiting
Childhood Cancer
Interventions
DRUG:
Ondansetron, dexamethasone, aprepitant
DRUG:
Ondansetron, Dexamethasone, placebo
Sponsor
University of Oklahoma